Ypsomed Holding AG | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
EUR5.8 |
Market Cap |
EUR1.52 B |
Shares Outstanding |
12.65 M |
Public Float |
- |
Ypsomed Holding AG | |
Stock Exchange | SIX Swiss Exchange |
EPS |
CHF6.73 |
Market Cap |
CHF1.72 B |
Shares Outstanding |
12.65 M |
Public Float |
3.3 M |
Address |
Brunnmattstrasse 6 Burgdorf Bern (Berne) 3401 Switzerland |
Employees | - |
Website | http://www.ypsomed.com |
Updated | 07/08/2019 |
Ypsomed Holding AG engages in the development and manufacture of injection systems for self-medication of drugs by patients, most notably used to treat diabetes. Its products include DiaExpert, BGMS, OmniPod, YpsoPump & Orbit, Pen needles, Injection systems, and Contract manufacturing. The company operates through the following business segments: Ypsomed Diabetes Care, Ypsomed Delivery Systems. |